Stay updated with the latest ischemia news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on ischemia topics.
Stempeutics will have to meet certain regulatory milestones, he said, as the product would be made in India and sent to Japan In a first of sorts in stem cell therapy, India's Stempeutics has inked an "option licence agreement" with Japan's Medinet, a listed company focussed on regenerative medicine - to take the former's product used in treating chronic limb threatening ischemia (CLTI), to Japan. Japan is a tough regulatory market, BN Manohar, Stempeutics Chief Executive Officer told business ...Read More >
Bangalore : In a remarkable story of resilience, advanced medical care, and the generosity of organ donation, doctors successfully performed a life-saving heart transplant on a 63-year-old man from Madanapalle who was battling end-stage heart failure. Once active and healthy, the patient's life took a dramatic turn after a massive heart attack severely damaged his heart. He became hospital-bound with repeated episodes of heart failure, ultimately requiring continuous IV inotropic therapy (milri ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.